99% of short-term radon tests give inaccurate results compared to long-term monitoring, but real estate transactions still rely on 2-day test kits

A 2019 University of Calgary study compared 5-day radon test results with 90-day test results in the same homes and found that 99% of short-term tests were inaccurate relative to long-term monitoring. Radon levels fluctuate dramatically day to day and season to season — driven by soil moisture, wind, barometric pressure, and HVAC operation. A 2-day test captures a snapshot that may have almost no relationship to actual annual exposure. Yet short-term tests remain the standard in real estate transactions across the United States, where the entire radon evaluation happens during a 5-10 day inspection contingency period. The health stakes are enormous. The EPA estimates radon causes approximately 21,000 lung cancer deaths per year in the United States — making it the second leading cause of lung cancer after smoking. Radon exposure is not a minor contributor; it is the number one cause of lung cancer among non-smokers. A home buyer who gets a short-term test result of 2.5 pCi/L (below the EPA action level of 4.0 pCi/L) may feel safe, but the actual annual average could be 6.0 pCi/L or higher. That buyer moves in, lives there for 15 years, and has been unknowingly exposed to a Class A carcinogen the entire time because a test that is wrong 99% of the time told them everything was fine. This problem persists because the real estate transaction timeline is structurally incompatible with accurate radon measurement. Buyers have days, not months, to complete due diligence. Sellers have no incentive to run long-term tests proactively — a high result would require disclosure and mitigation before listing. Testing companies profit from selling $15-30 short-term kits. Home inspectors include radon as an add-on service and need results within the inspection window. The EPA itself acknowledges that long-term tests are more accurate but still describes short-term tests as an acceptable 'screening' method, lending them an air of legitimacy they do not deserve for health decision-making.